Kent Branson, MD
Obstetrics & Gynecology · Creve Coeur, MONPI 1427149038
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,699 of the $2,654 with a category attached, or 64.0%. Pfizer accounts for 60.6% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $1,759 and has fallen 91.5% since, to $150 in 2025.
Across 67 payments — averaging $39.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$2K
- Evofem Biosciences, Inc.$398
- AbbVie$297
- Exeltis, USA Inc.$83
- Mayne Pharma Commercial LLC$74
- Vertical Pharmaceuticals, LLC$46
- plus $146 from 7 others
Across 125 payments — averaging $4584.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$372K
- Ventana Medical Systems, Inc.$109K
- GSK$69K
- Organon$19K
- Myovant Sciences Inc.$4K
What the payments were for
- Travel & lodging$95436%
- Food & beverage$1,69964%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 4 | $1,609 |
| Evofem Biosciences, Inc. | 21 | $398 |
| AbbVie(2 entities) | 22 | $297 |
| Exeltis, USA Inc. | 4 | $83 |
| Mayne Pharma Commercial LLC | 4 | $74 |
| Vertical Pharmaceuticals, LLC | 3 | $46 |
| Lupin Inc. | 3 | $38 |
| Mission Pharmacal Company | 1 | $26 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Abbott | 1 | $19 |
| Hologic Sales And Service, LLC | 1 | $16 |
| Aesculap, Inc. | 1 | $13 |
| Therapeuticsmd, Inc. | 1 | $12 |
How this compares
$2,654 in reported general payments places this provider in the 80th percentile of 750 obstetrics & gynecology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 36 | $511 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Creve Coeur
- Thomas ShultzSpringfield$1.1M
- Becky LynnSaint Louis$231K
- Timothy HallIndependence$172K
- Craig McCoyMoberly$101K
- Richard GutknechtIndependence$65K
- Amanda CarrollFestus$55K
- Amy CarterKansas City$49K
- Megan SneedLees Summit$44K
- Kimberly LemoineSaint Louis$30K
- Carrie CardaPoplar Bluff$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.